View More Recent Stories

Nov 5, 2015 09:00AM Epizyme Announces Presentations at 57th American Society of Hematology Annual Meeting
Nov 4, 2015 08:00AM Epizyme to Present New Scientific Data on the Role of HMT Inhibitors in Cancer
Nov 2, 2015 07:30AM Epizyme to Report Third Quarter 2015 Financial Results and Provide Corporate Update on November 9, 2015
Sep 26, 2015 05:25AM Epizyme Announces Updated Tazemetostat Phase 1 Data Showing Clinical Activity in a Broader Range of Adults With INI1-Negative and SMARCA4-Negative Solid Tumors
Aug 31, 2015 08:00AM Epizyme, Inc. to Present at Upcoming Events in September
Aug 24, 2015 08:00AM Epizyme Announces Acceptance of Investigational New Drug Application for Tazemetostat in Patients with INI1-Negative Tumors or Synovial Sarcoma
Aug 6, 2015 07:00AM Epizyme Announces Second Quarter 2015 Financial Results and Provides Corporate Update
Aug 5, 2015 04:10PM Epizyme Appoints Robert Bazemore President and Chief Executive Officer
Aug 4, 2015 08:00AM Epizyme, Inc. to Present at 2015 Wedbush PacGrow Healthcare Conference
Jul 30, 2015 08:00AM Epizyme to Report Second Quarter 2015 Financial Results and Provide Corporate Update on August 6, 2015
Jul 9, 2015 04:00PM Epizyme Doses First Patient in Five-Arm Phase 2 Study for First-in-Class EZH2 Inhibitor Tazemetostat (EPZ-6438) in Relapsed or Refractory Non-Hodgkin Lymphoma
Jul 9, 2015 07:00AM Epizyme Announces Extension of Celgene Research Collaboration
Jun 29, 2015 04:34PM Epizyme to Present Clinical Data from Ongoing Phase 1 Dose Escalation Trial of Tazemetostat (EPZ-6438) at the European Cancer Congress
Jun 22, 2015 05:21PM Market Wrap: Existing Home Sales Outpace in May; Twitter Details CEO Search; Merger Monday
Jun 20, 2015 04:40AM Epizyme Announces Additional Positive Data from Ongoing Phase 1 Study of Tazemetostat (EPZ-6438) in Relapsed or Refractory Non-Hodgkin Lymphoma
Jun 15, 2015 08:00AM Epizyme, Inc. to Present at Upcoming Events in June
Apr 30, 2015 04:30PM Epizyme to Present at Upcoming Conferences in May
Apr 28, 2015 04:01PM Epizyme Announces First Quarter 2015 Financial Results and Provides Corporate Update
Apr 27, 2015 03:05PM Trading Radar for 4/28: Ford (F), Aetna (AET), Twitter (TWTR), GoPro (GPRO), Panera Bread (PNRA) Report
Apr 21, 2015 04:30PM Epizyme to Report First Quarter 2015 Financial Results and Provide Corporate Update on April 28, 2015
Apr 20, 2015 05:35PM Epizyme Presents Preclinical Research Providing Deeper Understanding of Multiple Cancer Targets
Apr 20, 2015 08:30AM Epizyme to Present Updated Data from Ongoing Phase 1 Dose Escalation Trial of EZH2 Inhibitor EPZ-6438 at International Conference on Malignant Lymphoma
Mar 18, 2015 06:31PM Epizyme to Present Data on Preclinical Pipeline at the American Association for Cancer Research (AACR) Annual Meeting
Mar 12, 2015 07:00AM Epizyme Reacquires Global Rights from Eisai for First-in-Class EZH2 Inhibitor EPZ-6438
Mar 12, 2015 07:00AM Epizyme Announces 2014 Financial Results and Provides Corporate Update
Mar 5, 2015 07:30AM Epizyme to Report Fourth Quarter 2014 Financial Results and Provide Corporate Update on March 12, 2015
View More Recent Stories